Inflammation and fatness in adolescents with and without Down syndrome: UP & DOWN study

[Background]: The main objective of this study was to describe the inflammatory status of adolescents with Down syndrome (DS) and their relationship with adiposity.
[Methods]: Ninety‐five adolescents with DS (44.2% girls) and a control group of 113 adolescents (47.8% girls), aged between 11 and 18 years old, from the UP & DOWN study were included in this substudy. Serum C‐reactive protein, C3 and C4 complement factors, total proteins, interleukin‐6, tumour necrosis factor‐α, insulin, cortisol, leptin, adiponectin, galactin‐3 and visfatin were analysed; homeostatic model assessment index was calculated. In order to evaluate adiposity, we measured the following body fat variables: weight, height, waist circumference and skinfold thicknesses. Birth weight was obtained by questionnaire. In addition, body mass index, waist‐to‐height ratio (WHtR) and body fat percentage (BF%) were calculated.
[Results]: Down syndrome group showed higher levels of body mass index, WHtR, waist circumference, BF% and lower birth weight than controls (P < 0.001). In the general linear model in the total sample, WHtR was positively associated with C3 and C4 (P < 0.001) as well as with leptin levels (P = 0.015). BF% was positively associated with total proteins (P = 0.093) and leptin levels (P < 0.001). DS was positively associated with total proteins (P < 0.001), C3 (P = 0.047) and C4 (P = 0.019). Despite the higher levels of adiposity found in DS group, no direct association was found between BF% and leptin levels, comparing with the control group.
[Conclusions]: These findings suggest that abdominal obesity should be controlled in adolescents because of its relationship with acute phase‐inflammatory biomarkers but especially in DS adolescents who may show a peculiar metabolic status according to their relationship between adiposity and inflammatory biomarkers.
We appreciate the following financial support: DEP 2010‐21662‐C04‐00 grants from the National Plan for Research, Development and Innovation (R + D + i) MICINN.